{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:03:26Z","timestamp":1789736606742,"version":"4.0.1"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ejim.2024.12.034","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T17:06:26Z","timestamp":1739639186000},"page":"75-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Hypertensive heart disease in older patients: considerations for clinical practice"],"prefix":"10.1016","volume":"134","author":[{"given":"Miguel","family":"Camafort","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1090-4965","authenticated-orcid":false,"given":"Alexandros","family":"Kasiakogias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Agabiti-Rosei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Masi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5768-9125","authenticated-orcid":false,"given":"Panagiotis","family":"Iliakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanase","family":"Benetos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ok","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lorenza","family":"Muiesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Sudano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costas","family":"Tsioufis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ejim.2024.12.034_bib0001","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"issue":"10304","key":"10.1016\/j.ejim.2024.12.034_bib0002","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","year":"2021","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ejim.2024.12.034_bib0003","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41440-024-01622-w","article-title":"The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy","volume":"47","author":"Kario","year":"2024","journal-title":"Hypertension Research"},{"issue":"8","key":"10.1016\/j.ejim.2024.12.034_bib0004","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics\u20142022 update: a report from the american heart association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ejim.2024.12.034_bib0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/HYPERTENSIONAHA.121.18192","article-title":"Hypertension pharmacological treatment in adults: a world health organization guideline executive summary","volume":"79","author":"Al-Makki","year":"2022","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ejim.2024.12.034_bib0006","article-title":"The social, economic, and public health consequences of global population aging: implications for social work practice and public policy","volume":"2","author":"Kaplan","year":"2017","journal-title":"J Soc Work Glob Community"},{"issue":"2","key":"10.1016\/j.ejim.2024.12.034_bib0007","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/ehjqcco\/qcad033","article-title":"Burden of cardiovascular disease among elderly: based on the Global Burden of Disease Study 2019","volume":"10","author":"Qu","year":"2024","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"14","key":"10.1016\/j.ejim.2024.12.034_bib0008","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/heartjnl-2022-322117","article-title":"Cardiogeriatrics: the current state of the art","volume":"110","author":"Gaur","year":"2024","journal-title":"Heart"},{"key":"10.1016\/j.ejim.2024.12.034_bib0009","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.hjc.2023.03.006","article-title":"Cardiorenal multimorbidity in hospitalized cardiology patients: the hellenic cardiorenal morbidity snapshot (HECMOS) study","volume":"74","author":"Leontsinis","year":"2023","journal-title":"Hellenic J Cardiol"},{"issue":"18","key":"10.1016\/j.ejim.2024.12.034_bib0010","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejim.2024.12.034_bib0011","first-page":"158","article-title":"Beyond chronological age: a multidimensional approach to survival prediction in older adults","volume":"78","author":"Salignon","year":"2023","journal-title":"The Journals of Gerontology: Series A"},{"issue":"7","key":"10.1016\/j.ejim.2024.12.034_bib0012","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/CIRCRESAHA.118.313236","article-title":"Hypertension management in older and frail older patients","volume":"124","author":"Benetos","year":"2019","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.ejim.2024.12.034_bib0013","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/j.1532-5415.2005.53512.x","article-title":"Comorbidity is a better predictor of impaired immunity than chronological age in older adults","volume":"53","author":"Castle","year":"2005","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"10.1016\/j.ejim.2024.12.034_bib0014","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1111\/jch.14004","article-title":"Hypertension, heart failure, and frailty in older people: a common but unclear situation","volume":"22","author":"Camafort","year":"2020","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.ejim.2024.12.034_bib0015","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/906103","article-title":"Hypoglycemia is independently associated with multidimensional impairment in elderly diabetic patients","author":"Pilotto","year":"2014","journal-title":"Biomed Res Int"},{"issue":"9","key":"10.1016\/j.ejim.2024.12.034_bib0016","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.cjca.2016.05.005","article-title":"Heart failure in older adults","volume":"32","author":"Butrous","year":"2016","journal-title":"Can J Cardiol"},{"issue":"5","key":"10.1016\/j.ejim.2024.12.034_bib0017","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jcin.2012.02.012","article-title":"Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation","volume":"5","author":"Stortecky","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"issue":"20","key":"10.1016\/j.ejim.2024.12.034_bib0018","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.jacc.2010.06.039","article-title":"Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery","volume":"56","author":"Afilalo","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ejim.2024.12.034_bib0019","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/HYPERTENSIONAHA.115.07020","article-title":"An expert opinion from the european society of hypertension-european union geriatric medicine society working group on the management of hypertension in very old, frail subjects","volume":"67","author":"Benetos","year":"2016","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.ejim.2024.12.034_bib0020","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"10.1016\/j.ejim.2024.12.034_bib0021","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/gerona\/glab226","article-title":"Intrinsic capacity: validation of a new WHO concept for healthy aging in a longitudinal Chinese study","volume":"77","author":"Beard","year":"2022","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.ejim.2024.12.034_bib0022","series-title":"Integrated care for older people (ICOPE): guidance for person-centred assessment and pathways in primary care","year":"2019"},{"issue":"2","key":"10.1016\/j.ejim.2024.12.034_bib0023","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cger.2010.02.002","article-title":"The assessment of frailty in older adults","volume":"26","author":"Abellan van Kan","year":"2010","journal-title":"Clin Geriatr Med"},{"issue":"5","key":"10.1016\/j.ejim.2024.12.034_bib0024","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood","year":"2005","journal-title":"CMAJ"},{"issue":"10","key":"10.1016\/j.ejim.2024.12.034_bib0025","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jacc.2009.09.061","article-title":"Pulse pressure amplification a mechanical biomarker of cardiovascular risk","volume":"55","author":"Benetos","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ejim.2024.12.034_bib0026","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/ajh\/hps092","article-title":"Pulse pressure and subclinical cardiovascular disease in the multi-ethnic study of atherosclerosis","volume":"26","author":"Winston","year":"2013","journal-title":"Am J Hypertens"},{"issue":"6","key":"10.1016\/j.ejim.2024.12.034_bib0027","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 international society of hypertension global hypertension practice guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.ejim.2024.12.034_bib0028","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/HJH.0000000000002843","article-title":"2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement","volume":"39","author":"Stergiou","year":"2021","journal-title":"J Hypertens"},{"issue":"6","key":"10.1016\/j.ejim.2024.12.034_bib0029","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/ajh.2011.23","article-title":"Masked hypertension in the elderly: cross-sectional analysis of a population-based sample","volume":"24","author":"Cacciolati","year":"2011","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.1016\/j.ejim.2024.12.034_bib0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.36628\/ijhf.2022.0032","article-title":"Lifestyle modification in heart failure management: are we using evidence-based recommendations in real world practice?","volume":"5","author":"Camafort","year":"2023","journal-title":"International journal of heart failure"},{"key":"10.1016\/j.ejim.2024.12.034_bib0031","doi-asserted-by":"crossref","unstructured":"Camafort M, Chung WJ, Shin JH. Role of ambulatory blood pressure monitoring in elderly hypertensive patients. Clin Hypertens. 2022;28(1):22. doi:10.1186\/s40885-022-00205-6.","DOI":"10.1186\/s40885-022-00205-6"},{"issue":"5","key":"10.1016\/j.ejim.2024.12.034_bib0032","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1093\/ageing\/afab090","article-title":"Prevalence of initial orthostatic hypotension in older adults: a systematic review and meta-analysis","volume":"50","author":"Tran","year":"2021","journal-title":"Age Ageing"},{"issue":"1","key":"10.1016\/j.ejim.2024.12.034_bib0033","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/jch.14409","article-title":"The effect of frailty on the 24-hour blood pressure pattern in the very elderly","volume":"24","author":"Blauth","year":"2022","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"2","key":"10.1016\/j.ejim.2024.12.034_bib0034","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/jamacardio.2019.4973","article-title":"Age-related differences in the noninvasive evaluation for possible coronary artery disease: insights from the prospective multicenter imaging study for evaluation of chest pain (PROMISE) trial","volume":"5","author":"Lowenstern","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"4","key":"10.1016\/j.ejim.2024.12.034_bib0035","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0735-1097(01)01110-X","article-title":"Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study","volume":"37","author":"Aurigemma","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ejim.2024.12.034_bib0036","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jacc.2018.10.038","article-title":"ACC\/AATS\/AHA\/ASE\/ASNC\/HRS\/SCAI\/SCCT\/SCMR\/STS 2019 appropriate use criteria for multimodality imaging in the assessment of cardiac structure and function in nonvalvular heart disease","volume":"73","author":"Doherty","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.ejim.2024.12.034_bib0037","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/ehjci\/jew333","article-title":"EACVI appropriateness criteria for the use of transthoracic echocardiography in adults: a report of literature and current practice review","volume":"18","author":"Steeds","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.ejim.2024.12.034_bib0038","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/CIRCULATIONAHA.110.937821","article-title":"Correlates of echocardiographic indices of cardiac remodeling over the adult life course: longitudinal observations from the Framingham Heart Study","volume":"122","author":"Cheng","year":"2010","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ejim.2024.12.034_bib0039","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/CIRCIMAGING.108.819938","article-title":"Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: the Multi-Ethnic Study of Atherosclerosis","volume":"2","author":"Cheng","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.ejim.2024.12.034_bib0040","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.004510","article-title":"Age- and sex-related influences on left ventricular mechanics in elderly individuals free of prevalent heart failure: the ARIC study (atherosclerosis risk in communities)","volume":"10","author":"Hung","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.ejim.2024.12.034_bib0041","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12968-020-00683-3","article-title":"Reference ranges (\u201cnormal values\u201d) for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update","volume":"22","author":"Kawel-Boehm","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"issue":"4","key":"10.1016\/j.ejim.2024.12.034_bib0042","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/ehjci\/jew284","article-title":"3D echocardiographic reference ranges for normal left ventricular volumes and strain: results from the EACVI NORRE study","volume":"18","author":"Bernard","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.ejim.2024.12.034_bib0043","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/10976640600572889","article-title":"Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance","volume":"8","author":"Maceira","year":"2006","journal-title":"J Cardiovasc Magn Reson"},{"issue":"12","key":"10.1016\/j.ejim.2024.12.034_bib0044","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.jcmg.2012.07.014","article-title":"Population-based reference values for 3D echocardiographic LV volumes and ejection fraction","volume":"5","author":"Chahal","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"issue":"11","key":"10.1016\/j.ejim.2024.12.034_bib0045","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0002-9149(02)02840-0","article-title":"Left ventricular remodeling with age in normal men versus women: novel insights using three-dimensional magnetic resonance imaging","volume":"90","author":"Hees","year":"2002","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.ejim.2024.12.034_bib0046","first-page":"1390","article-title":"Normal reference values of multilayer longitudinal strain according to age decades in a healthy population: a single-centre experience","volume":"19","author":"Alcidi","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.ejim.2024.12.034_bib0047","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1161\/01.RES.68.6.1560","article-title":"Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy","volume":"68","author":"Olivetti","year":"1991","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.ejim.2024.12.034_bib0048","first-page":"158","article-title":"Aging and cardiac fibrosis","volume":"2","author":"Biernacka","year":"2011","journal-title":"Aging Dis"},{"issue":"14","key":"10.1016\/j.ejim.2024.12.034_bib0049","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jacc.2013.05.078","article-title":"Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"62","author":"Liu","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ejim.2024.12.034_bib0050","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12968-017-0371-5","article-title":"Age and sex corrected normal reference values of T1, T2 T2* and ECV in healthy subjects at 3T CMR","volume":"19","author":"Roy","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"issue":"11","key":"10.1016\/j.ejim.2024.12.034_bib0051","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jcmg.2020.04.021","article-title":"Defining myocardial abnormalities across the stages of chronic kidney disease: a cardiac magnetic resonance imaging study","volume":"13","author":"Hayer","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.ejim.2024.12.034_bib0052","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCOUTCOMES.111.962688","article-title":"Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007","volume":"5","author":"Piccini","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"3","key":"10.1016\/j.ejim.2024.12.034_bib0053","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1540-8175.2008.00806.x","article-title":"Prevalence, clinical correlates, and prognosis of discrete upper septal thickening on echocardiography: the framingham heart study","volume":"26","author":"Diaz","year":"2009","journal-title":"Echocardiography"},{"issue":"14","key":"10.1016\/j.ejim.2024.12.034_bib0054","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/heartjnl-2015-308764","article-title":"Distinguishing ventricular septal bulge versus hypertrophic cardiomyopathy in the elderly","volume":"102","author":"Canepa","year":"2016","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.ejim.2024.12.034_bib0055","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1097\/HJH.0000000000002813","article-title":"Septal curvature as a robust and reproducible marker for basal septal hypertrophy","volume":"39","author":"Marciniak","year":"2021","journal-title":"J Hypertens"},{"issue":"9","key":"10.1016\/j.ejim.2024.12.034_bib0056","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0002-9149(96)00542-5","article-title":"Age-associated changes in left ventricular outflow tract geometry in normal subjects","volume":"78","author":"Swinne","year":"1996","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.ejim.2024.12.034_bib0057","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11897-012-0114-8","article-title":"Aging of the United States population: impact on heart failure","volume":"9","author":"Vigen","year":"2012","journal-title":"Curr Heart Fail Rep"},{"issue":"8","key":"10.1016\/j.ejim.2024.12.034_bib0058","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/HJH.0000000000002910","article-title":"Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension","volume":"39","author":"Kasiakogias","year":"2021","journal-title":"J Hypertens"},{"issue":"15","key":"10.1016\/j.ejim.2024.12.034_bib0059","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.ejim.2024.12.034_bib0060","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"issue":"36","key":"10.1016\/j.ejim.2024.12.034_bib0061","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.ejim.2024.12.034_bib0062","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.amjcard.2005.10.030","article-title":"Left ventricular geometry and survival in patients with normal left ventricular ejection fraction","volume":"97","author":"Milani","year":"2006","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.ejim.2024.12.034_bib0063","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.amjcard.2006.06.037","article-title":"Left ventricular geometry and mortality in patients >70 years of age with normal ejection fraction","volume":"98","author":"Lavie","year":"2006","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ejim.2024.12.034_bib0064","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1148\/radiol.2015150982","article-title":"Adverse left ventricular remodeling and age assessed with cardiac mr imaging: the multi-ethnic study of atherosclerosis","volume":"278","author":"Eng","year":"2016","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.ejim.2024.12.034_bib0065","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/01.HYP.29.2.539","article-title":"High prevalence of concentric remodeling in elderly individuals with isolated systolic hypertension from a population survey","volume":"29","author":"Heesen","year":"1997","journal-title":"Hypertension"},{"issue":"8 Pt 1","key":"10.1016\/j.ejim.2024.12.034_bib0066","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0895-7061(01)01292-4","article-title":"Similar effects of isolated systolic and combined hypertension on left ventricular geometry and function: the LIFE Study","volume":"14","author":"Papademetriou","year":"2001","journal-title":"Am J Hypertens"},{"issue":"11","key":"10.1016\/j.ejim.2024.12.034_bib0067","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/01.CIR.0000141573.44737.5A","article-title":"Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial","volume":"110","author":"Devereux","year":"2004","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.ejim.2024.12.034_bib0068","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"New England J Med"},{"issue":"4","key":"10.1016\/j.ejim.2024.12.034_bib0069","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1002\/ehf2.13349","article-title":"Left ventricular geometry transition in hypertensive patients with heart failure with preserved ejection fraction","volume":"8","author":"Guan","year":"2021","journal-title":"ESC Heart Fail"},{"issue":"2","key":"10.1016\/j.ejim.2024.12.034_bib0070","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/HJH.0000000000001897","article-title":"Change in left ventricular geometry over 10 years in the elderly and risk of incident cardiovascular disease","volume":"37","author":"Lind","year":"2019","journal-title":"J Hypertens"},{"issue":"9","key":"10.1016\/j.ejim.2024.12.034_bib0071","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0002-9149(87)91136-2","article-title":"Effect of aging on left ventricular diastolic filling in normal subjects","volume":"59","author":"Bryg","year":"1987","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.ejim.2024.12.034_bib0072","first-page":"1031","article-title":"Echocardiographic reference ranges for normal cardiac Doppler data: results from the NORRE Study","volume":"16","author":"Caballero","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.ejim.2024.12.034_bib0073","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10554-018-1480-4","article-title":"Influence of age and sex on left ventricular diastolic strain analysis","volume":"35","author":"van Grootel","year":"2019","journal-title":"Int J Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.ejim.2024.12.034_bib0074","first-page":"252","article-title":"Assessment and impact of diastolic function by echocardiography in elderly patients","volume":"13","author":"Dugo","year":"2016","journal-title":"J Geriatr Cardiol"},{"issue":"5","key":"10.1016\/j.ejim.2024.12.034_bib0075","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1161\/CIRCULATIONAHA.116.024825","article-title":"Contemporary assessment of left ventricular diastolic function in older adults: the atherosclerosis risk in communities study","volume":"135","author":"Shah","year":"2017","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.ejim.2024.12.034_bib0076","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1161\/CIRCULATIONAHA.108.838698","article-title":"Age-associated increases in pulmonary artery systolic pressure in the general population","volume":"119","author":"Lam","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ejim.2024.12.034_bib0077","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0195-668X(02)00428-1","article-title":"Prevalence of left ventricular diastolic dysfunction in the community Results from a Doppler echocardiographic-based survey of a population sample","volume":"24","author":"Fischer","year":"2003","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.ejim.2024.12.034_bib0078","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1136\/heartjnl-2012-302457","article-title":"Prevalence of left ventricular dysfunction in a UK community sample of very old people: the Newcastle 85+ study","volume":"98","author":"Yousaf","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.ejim.2024.12.034_bib0079","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.749523","article-title":"Incidence and characterization of concealed cardiac amyloidosis among unselected elderly patients undergoing post-mortem examination","volume":"8","author":"Porcari","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.ejim.2024.12.034_bib0080","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jcmg.2015.04.012","article-title":"Coexistence of degenerative aortic stenosis and wild-type transthyretin-related cardiac amyloidosis","volume":"9","author":"Longhi","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"issue":"11","key":"10.1016\/j.ejim.2024.12.034_bib0081","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/jamacardio.2021.3070","article-title":"Prevalence of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction","volume":"6","author":"AbouEzzeddine","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.ejim.2024.12.034_bib0082","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.hjc.2019.10.004","article-title":"Transthyretin cardiac amyloidosis in aortic stenosis: Prevalence, diagnostic challenges, and clinical implications","volume":"61","author":"Balciunaite","year":"2020","journal-title":"Hellenic J Cardiol"},{"issue":"10","key":"10.1016\/j.ejim.2024.12.034_bib0083","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2017.9236","article-title":"Association between ruptured distal biceps tendon and wild-type transthyretin cardiac amyloidosis","volume":"318","author":"Geller","year":"2017","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ejim.2024.12.034_bib0084","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the american college of cardiology solution set oversight committee","volume":"81","author":"Committee","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ejim.2024.12.034_bib0085","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/ehjci\/jeaa063","article-title":"Multimodality imaging in cardiac amyloidosis: a primer for cardiologists","volume":"21","author":"Jurcu\u0163","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"11","key":"10.1016\/j.ejim.2024.12.034_bib0086","first-page":"894","article-title":"Review on the management of cardiovascular risk factors in the elderly","volume":"19","author":"Gonz\u00e1lez-Cola\u00e7o Harmand","year":"2022","journal-title":"J Geriatr Cardiol"},{"issue":"18","key":"10.1016\/j.ejim.2024.12.034_bib0087","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.jacc.2017.12.068","article-title":"Coronary artery disease in patients \u226580 years of age","volume":"71","author":"Madhavan","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ejim.2024.12.034_bib0088","first-page":"9","article-title":"Non-ST elevation acute coronary syndrome in the elderly","volume":"17","author":"D\u00edez-Villanueva","year":"2020","journal-title":"J Geriatr Cardiol"},{"issue":"3","key":"10.1016\/j.ejim.2024.12.034_bib0089","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ahj.2007.04.061","article-title":"Stress echocardiography, stress single-photon-emission computed tomography and electron beam computed tomography for the assessment of coronary artery disease: a meta-analysis of diagnostic performance","volume":"154","author":"Heijenbrok-Kal","year":"2007","journal-title":"Am Heart J"},{"issue":"7","key":"10.1016\/j.ejim.2024.12.034_bib0090","first-page":"507","article-title":"The utility of coronary computed tomography angiography in elderly patients","volume":"16","author":"Laggoune","year":"2019","journal-title":"J Geriatr Cardiol"},{"issue":"1","key":"10.1016\/j.ejim.2024.12.034_bib0091","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/agm2.12015","article-title":"Atrial fibrillation in aging population","volume":"1","author":"Chen","year":"2018","journal-title":"Aging Med (Milton)"},{"issue":"11","key":"10.1016\/j.ejim.2024.12.034_bib0092","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1093\/eurjpc\/zwab005","article-title":"The relationship between blood pressure and risk of atrial fibrillation: a Mendelian randomization study","volume":"29","author":"Georgiopoulos","year":"2022","journal-title":"Eur J Prev Cardiol"},{"issue":"5","key":"10.1016\/j.ejim.2024.12.034_bib0093","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/europace\/euv021","article-title":"Effect of antihypertensive agents on risk of atrial fibrillation: a meta-analysis of large-scale randomized trials","volume":"17","author":"Emdin","year":"2015","journal-title":"Europace"},{"issue":"6","key":"10.1016\/j.ejim.2024.12.034_bib0094","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1161\/HYPERTENSIONAHA.120.14766","article-title":"Effect of intensive blood pressure lowering on the risk of atrial fibrillation","volume":"75","author":"Soliman","year":"2020","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.ejim.2024.12.034_bib0095","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1161\/CIRCULATIONAHA.122.060274","article-title":"Early rhythm control in patients with atrial fibrillation and high comorbidity burden","volume":"146","author":"Rillig","year":"2022","journal-title":"Circulation"},{"issue":"40","key":"10.1016\/j.ejim.2024.12.034_bib0096","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta9400","article-title":"A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study","volume":"9","author":"Hobbs","year":"2005","journal-title":"Health Technol Assess"},{"issue":"3","key":"10.1016\/j.ejim.2024.12.034_bib0097","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.hrthm.2008.11.033","article-title":"Impact of atrial prevention pacing on atrial fibrillation burden: primary results of the Study of Atrial Fibrillation Reduction (SAFARI) trial","volume":"6","author":"Gold","year":"2009","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.ejim.2024.12.034_bib0098","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/HYPERTENSIONAHA.122.19459","article-title":"Atrial fibrillation detection and management in hypertension","volume":"80","author":"Gawa\u0142ko","year":"2023","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.ejim.2024.12.034_bib0099","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jchf.2014.12.018","article-title":"Older adults, \u201cmalignant\u201d left ventricular hypertrophy, and associated cardiac-specific biomarker phenotypes to identify the differential risk of new-onset reduced versus preserved ejection fraction heart failure: chs (cardiovascular health study)","volume":"3","author":"Seliger","year":"2015","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.ejim.2024.12.034_bib0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/jhh.2011.113","article-title":"Inflammatory markers are associated with left ventricular hypertrophy and diastolic dysfunction in a population-based sample of elderly men and women","volume":"27","author":"Masiha","year":"2013","journal-title":"J Hum Hypertens"},{"issue":"5","key":"10.1016\/j.ejim.2024.12.034_bib0101","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/HYPERTENSIONAHA.111.178095","article-title":"Biomarkers of left ventricular hypertrophy and remodeling in blacks","volume":"58","author":"Coutinho","year":"2011","journal-title":"Hypertension"},{"issue":"13","key":"10.1016\/j.ejim.2024.12.034_bib0102","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.jacc.2020.07.055","article-title":"Cardiovascular Biomarkers and Imaging in Older Adults: JACC Council Perspectives","volume":"76","author":"Forman","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.ejim.2024.12.034_bib0103","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","article-title":"Trial of intensive blood-pressure control in older patients with hypertension","volume":"385","author":"Zhang","year":"2021","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.ejim.2024.12.034_bib0104","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.2016.7050","article-title":"Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged \u226575 years: a randomized clinical trial","volume":"315","author":"Williamson","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2024.12.034_bib0105","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension","author":"McEvoy","year":"2024","journal-title":"Eur Heart J. Published online"},{"issue":"6","key":"10.1016\/j.ejim.2024.12.034_bib0106","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"issue":"15","key":"10.1016\/j.ejim.2024.12.034_bib0107","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1001\/archinternmed.2012.2555","article-title":"Rethinking the association of high blood pressure with mortality in elderly adults: the impact of frailty","volume":"172","author":"Odden","year":"2012","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.ejim.2024.12.034_bib0108","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/ageing\/afv141","article-title":"Blood pressure and 10-year mortality risk in the milan geriatrics 75+ cohort study: role of functional and cognitive status","volume":"44","author":"Ogliari","year":"2015","journal-title":"Age Ageing"},{"issue":"1","key":"10.1016\/j.ejim.2024.12.034_bib0109","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.121.17530","article-title":"Systolic blood pressure and mortality in community-dwelling older adults: frailty as an effect modifier","volume":"79","author":"Kremer","year":"2022","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ejim.2024.12.034_bib0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/HYPERTENSIONAHA.121.18373","article-title":"How low should you go in the presence of frailty?","volume":"79","author":"Odden","year":"2022","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.ejim.2024.12.034_bib0111","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/jamainternmed.2014.8164","article-title":"Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs","volume":"175","author":"Mossello","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"6","key":"10.1016\/j.ejim.2024.12.034_bib0112","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/jamainternmed.2014.8012","article-title":"Treatment with multiple blood pressure medications, achieved blood pressure, and mortality in older nursing home residents: the PARTAGE study","volume":"175","author":"Benetos","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.ejim.2024.12.034_bib0113","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/HYPERTENSIONAHA.115.05800","article-title":"Defining thresholds for home blood pressure monitoring in octogenarians","volume":"66","author":"Aparicio","year":"2015","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.ejim.2024.12.034_bib0114","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/ageing\/afy072","article-title":"Lower blood pressure during antihypertensive treatment is associated with higher all-cause mortality and accelerated cognitive decline in the oldest-old. Data from the Leiden 85-plus Study","volume":"47","author":"Streit","year":"2018","journal-title":"Age Ageing"},{"issue":"11","key":"10.1016\/j.ejim.2024.12.034_bib0115","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s11906-022-01215-3","article-title":"Antihypertensive deprescribing in older adults: a practical guide","volume":"24","author":"Sheppard","year":"2022","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"10.1016\/j.ejim.2024.12.034_bib0116","doi-asserted-by":"crossref","first-page":"58","DOI":"10.7326\/M20-4298","article-title":"Effects of intensive blood pressure treatment on orthostatic hypotension : a systematic review and individual participant-based meta-analysis","volume":"174","author":"Juraschek","year":"2021","journal-title":"Ann Intern Med"},{"issue":"24","key":"10.1016\/j.ejim.2024.12.034_bib0117","first-page":"3255","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the systolic hypertension in the elderly program (SHEP)","volume":"265","year":"1991","journal-title":"SHEP Cooperat Res Group. JAMA"},{"issue":"9080","key":"10.1016\/j.ejim.2024.12.034_bib0118","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","article-title":"Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The systolic hypertension in Europe (Syst-Eur) trial investigators","volume":"350","author":"Staessen","year":"1997","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ejim.2024.12.034_bib0119","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMoa021716","article-title":"A comparison of outcomes with angiotensin-converting\u2013enzyme inhibitors and diuretics for hypertension in the elderly","volume":"348","author":"Wing","year":"2003","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ejim.2024.12.034_bib0120","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00004872-200305000-00011","article-title":"The study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind intervention trial","volume":"21","author":"Lithell","year":"2003","journal-title":"J Hypertens"},{"issue":"21","key":"10.1016\/j.ejim.2024.12.034_bib0121","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/eurheartj\/ehy037","article-title":"2018 ESC guidelines for the diagnosis and management of syncope","volume":"39","author":"Brignole","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2024.12.034_bib0122","doi-asserted-by":"crossref","first-page":"n189","DOI":"10.1136\/bmj.n189","article-title":"Association between antihypertensive treatment and adverse events: systematic review and meta-analysis","volume":"372","author":"Albasri","year":"2021","journal-title":"BMJ"},{"issue":"9215","key":"10.1016\/j.ejim.2024.12.034_bib0123","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","article-title":"Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-inhibitor myocardial infarction collaborative group","volume":"355","author":"Flather","year":"2000","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.ejim.2024.12.034_bib0124","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","article-title":"Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE inhibitor trials","volume":"273","author":"Garg","year":"1995","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ejim.2024.12.034_bib0125","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"New Eng J Med"},{"issue":"18","key":"10.1016\/j.ejim.2024.12.034_bib0126","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.ejim.2024.12.034_bib0127","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.jacc.2018.02.059","article-title":"Domain management approach to heart failure in the geriatric patient: present and future","volume":"71","author":"Gorodeski","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ejim.2024.12.034_bib0128","doi-asserted-by":"crossref","first-page":"14270","DOI":"10.1038\/s41598-018-32684-9","article-title":"Clinical characteristics and outcomes in the very elderly patients hospitalized for acute heart failure: importance of pharmacologic guideline adherence","volume":"8","author":"Sung","year":"2018","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.ejim.2024.12.034_bib0129","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ejhf.1799","article-title":"Heart failure treatment up-titration and outcome and age: an analysis of BIOSTAT-CHF","volume":"23","author":"Mordi","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.ejim.2024.12.034_bib0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jchf.2018.10.010","article-title":"Contemporary drug treatment of chronic heart failure with reduced ejection fraction: the CHECK-HF registry","volume":"7","author":"Brunner-La Rocca","year":"2019","journal-title":"JACC Heart Fail"},{"issue":"16","key":"10.1016\/j.ejim.2024.12.034_bib0131","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"New Eng J Med"},{"issue":"12","key":"10.1016\/j.ejim.2024.12.034_bib0132","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.ejim.2024.12.034_bib0133","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1161\/CIRCULATIONAHA.122.061754","article-title":"Efficacy and safety of dapagliflozin according to frailty in patients with heart failure: a prespecified analysis of the DELIVER trial","volume":"146","author":"Butt","year":"2022","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ejim.2024.12.034_bib0134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2022.04.040","article-title":"Empagliflozin improves outcomes in patients with heart failure and preserved ejection fraction irrespective of age","volume":"80","author":"B\u00f6hm","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ejim.2024.12.034_bib0135","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afac201","article-title":"The role of sodium-glucose co-transporter-2 inhibitors in frail older adults with or without type 2 diabetes mellitus","volume":"51","author":"Evans","year":"2022","journal-title":"Age Ageing"},{"issue":"1","key":"10.1016\/j.ejim.2024.12.034_bib0136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2022.04.040","article-title":"Empagliflozin improves outcomes in patients with heart failure and preserved ejection fraction irrespective of age","volume":"80","author":"B\u00f6hm","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ejim.2024.12.034_bib0137","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2337\/dc19-1476","article-title":"Efficacy and safety of dapagliflozin in the elderly: analysis from the DECLARE-TIMI 58 study","volume":"43","author":"Cahn","year":"2020","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.ejim.2024.12.034_bib0138","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s40266-016-0382-1","article-title":"Long-term safety of dapagliflozin in older patients with type 2 diabetes mellitus: a pooled analysis of phase IIb\/III studies","volume":"33","author":"Fioretto","year":"2016","journal-title":"Drugs Aging"},{"issue":"2","key":"10.1016\/j.ejim.2024.12.034_bib0139","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/CIRCULATIONAHA.119.044133","article-title":"Efficacy and safety of dapagliflozin in heart failure with reduced ejection fraction according to age: insights from DAPA-HF","volume":"141","author":"Martinez","year":"2020","journal-title":"Circulation"},{"issue":"46","key":"10.1016\/j.ejim.2024.12.034_bib0140","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.2174\/1381612825666190222145116","article-title":"Future anti-aldosterone agents","volume":"24","author":"Dimitriadis","year":"2018","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.ejim.2024.12.034_bib0141","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3904\/kjim.2020.623","article-title":"Is there sufficient evidence to justify changes in dietary habits in heart failure patients? A systematic review","volume":"37","author":"Garc\u00eda-Garc\u00eda","year":"2022","journal-title":"Korean J Intern Med"},{"issue":"9","key":"10.1016\/j.ejim.2024.12.034_bib0142","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jchf.2020.04.004","article-title":"Insufficient calorie intake worsens post-discharge quality of life and increases readmission burden in heart failure","volume":"8","author":"Bilgen","year":"2020","journal-title":"JACC Heart Fail"},{"issue":"36","key":"10.1016\/j.ejim.2024.12.034_bib0143","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European association for cardio-thoracic surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.ejim.2024.12.034_bib0144","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003821","article-title":"Drug-induced orthostatic hypotension: a systematic review and meta-analysis of randomised controlled trials","volume":"18","author":"Bhanu","year":"2021","journal-title":"PLoS Med"},{"issue":"14","key":"10.1016\/j.ejim.2024.12.034_bib0145","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1161\/CIRCULATIONAHA.120.050991","article-title":"Ablation versus drug therapy for atrial fibrillation in heart failure","volume":"143","author":"Packer","year":"2021","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ejim.2024.12.034_bib0146","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/HJH.0000000000002346","article-title":"Atrial fibrillation and the risk of cardiovascular disease and mortality in the Hypertension in the very elderly trial","volume":"38","author":"Antikainen","year":"2020","journal-title":"J Hypertens"},{"issue":"12","key":"10.1016\/j.ejim.2024.12.034_bib0147","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1161\/HYPERTENSIONAHA.122.19810","article-title":"Home blood pressure can predict the risk for stroke\/bleeding events in elderly patients with nonvalvular atrial fibrillation from the ANAFIE registry","volume":"79","author":"Kario","year":"2022","journal-title":"Hypertension"},{"issue":"10395","key":"10.1016\/j.ejim.2024.12.034_bib0148","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(23)00806-1","article-title":"The third intensive care bundle with blood pressure reduction in acute cerebral haemorrhage trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial","volume":"402","author":"Ma","year":"2023","journal-title":"The Lancet"},{"issue":"6","key":"10.1016\/j.ejim.2024.12.034_bib0149","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/eurheartj\/ehl504","article-title":"Effect of hypertension on anticoagulated patients with atrial fibrillation","volume":"28","author":"Lip","year":"2007","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.ejim.2024.12.034_bib0150","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002015","article-title":"Blood pressure control and risk of stroke or systemic embolism in patients with atrial fibrillation: results from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial","volume":"4","author":"Rao","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.ejim.2024.12.034_bib0151","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2019-001187","article-title":"Twelve-month outcome in patients with stroke and atrial fibrillation not suitable to oral anticoagulant strategy: the WATCH-AF registry","volume":"6","author":"Guidoux","year":"2019","journal-title":"Open Heart"},{"issue":"8","key":"10.1016\/j.ejim.2024.12.034_bib0152","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.amjmed.2012.01.033","article-title":"Risk of falls and major bleeds in patients on oral anticoagulation therapy","volume":"125","author":"Donz\u00e9","year":"2012","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.ejim.2024.12.034_bib0153","first-page":"279","article-title":"Safety of switching from a vitamin K antagonist to a non-vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL-AF randomized controlled trial","volume":"149","author":"Joosten","year":"2024","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ejim.2024.12.034_bib0154","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/STROKEAHA.114.007199","article-title":"Stroke and major bleeding risk in elderly patients aged \u226575 years with atrial fibrillation","volume":"46","author":"Lip","year":"2015","journal-title":"Stroke"},{"issue":"36","key":"10.1016\/j.ejim.2024.12.034_bib0155","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.ejim.2024.12.034_bib0156","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/eurjpc\/zwad004","article-title":"Optimal or standard control of systolic and diastolic blood pressure across risk factor categories in patients with chronic coronary syndromes","volume":"30","author":"Vidal-Petiot","year":"2023","journal-title":"Eur J Prev Cardiol"},{"issue":"23","key":"10.1016\/j.ejim.2024.12.034_bib0157","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1093\/eurheartj\/ehq328","article-title":"J-curve revisited: an analysis of blood pressure and cardiovascular events in the treating to new targets (TNT) trial","volume":"31","author":"Bangalore","year":"2010","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.ejim.2024.12.034_bib0158","doi-asserted-by":"crossref","first-page":"884","DOI":"10.7326\/0003-4819-144-12-200606200-00005","article-title":"Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?","volume":"144","author":"Messerli","year":"2006","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.ejim.2024.12.034_bib0159","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/01.CIR.83.3.845","article-title":"Upward shift of the lower range of coronary flow autoregulation in hypertensive patients with hypertrophy of the left ventricle","volume":"83","author":"Polese","year":"1991","journal-title":"Circulation"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524005405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524005405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T07:32:28Z","timestamp":1749108748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620524005405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":159,"alternative-id":["S0953620524005405"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2024.12.034","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertensive heart disease in older patients: considerations for clinical practice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2024.12.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}]}}